Nutra Pharma Corp (NPHC) Current Assets (2010 - 2026)

Nutra Pharma has disclosed Current Assets across 17 years of filings, most recently posting $463119.0 for Q2 2026.

• In Q2 2026, Current Assets fell 30.37% year-over-year to $463119.0; the TTM figure through Jun 2026 stood at $463119.0 (down 30.37% YoY), while the FY2025 annual figure was $459583.0, up 22.61% from the prior year.
• Current Assets came in at $463119.0 for Q2 2026 at Nutra Pharma, down from $499424.0 in the prior quarter.
• In the past five years, Current Assets ranged from a high of $665128.0 in Q2 2025 to a low of $310755.0 in Q3 2024.
• Average Current Assets over 5 years is $429371.4, with a median of $417640.5 recorded in 2023.
• The largest YoY upside for Current Assets was 181.55% in 2022 against a maximum downside of 37.51% in 2022.
• Over 5 years, Current Assets stood at $333577.0 in 2022, then retreated by 5.85% to $314060.0 in 2023, then rose by 19.35% to $374837.0 in 2024, then advanced by 22.61% to $459583.0 in 2025, then gained by 0.77% to $463119.0 in 2026.
• Per Business Quant data, the three most recent Current Assets figures were $463119.0 in Q2 2026, $499424.0 in Q1 2026, and $459583.0 in Q4 2025.